{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:05:20Z","timestamp":1789761920518,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.idnow.2026.105286","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:17:19Z","timestamp":1778836639000},"page":"105286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic drug monitoring in older adults treated with beta-lactams or daptomycin in a French tertiary hospital: A retrospective study (TEldBet)"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4292-1530","authenticated-orcid":false,"given":"Benjamin","family":"Festou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Tchalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2026.105286_b0005","unstructured":"Organisation Mondiale de la Sant\u00e9 [Internet]. 2025. Vieillissement et sant\u00e9 [cited July 17, 2025]. Available on: https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/ageing-and-health."},{"issue":"2","key":"10.1016\/j.idnow.2026.105286_b0010","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1086\/313947","article-title":"Clinical relevance of age-related immune dysfunction","volume":"31","author":"Castle","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idnow.2026.105286_b0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eurger.2010.01.010","article-title":"Immunological pathogenesis of main age-related diseases and frailty: Role of immunosenescence","volume":"1","author":"Lang","year":"2010","journal-title":"European Geriatric Medicine"},{"issue":"11","key":"10.1016\/j.idnow.2026.105286_b0020","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1432-2277.2009.00927.x","article-title":"The aging of the immune system","volume":"22","author":"Weiskopf","year":"2009","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.idnow.2026.105286_b0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccc.2013.03.016","article-title":"Infections in the elderly","volume":"29","author":"Hepper","year":"2013","journal-title":"Crit Care Clin"},{"issue":"9","key":"10.1016\/j.idnow.2026.105286_b0030","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/cis199","article-title":"Preeminence of Staphylococcus aureus in infective endocarditis: A 1-year population-based survey","volume":"54","author":"Selton-Suty","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2026.105286_b0035","unstructured":"Centre National de R\u00e9f\u00e9rence des Pneumocoques [Internet]. 201Rapport d\u2019activit\u00e9 2018-Epid\u00e9miologie 201[cited September, 15 2025]. Available on: https:\/\/cnr-pneumo.com\/docman\/rapports\/39-2018-epidemiologie-2017\/file."},{"key":"10.1016\/j.idnow.2026.105286_b0040","unstructured":"Lucado J, Gould C, Elixhauser A. Clostridium Difficile Infections (CDI) in Hospital Stays, 2009. 2012 Jan. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-. Statistical Brief #124 [cited September 15, 2025]. Available on: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK92613\/."},{"key":"10.1016\/j.idnow.2026.105286_b0045","unstructured":"European Society of Cardiology [Internet]. 2023. 2023 ESC Guidelines for the management of endocarditis [cited September 12, 2025]. Available on: https:\/\/www.escardio.org\/Guidelines\/Clinical-Practice-Guidelines\/Endocarditis-Guidelines."},{"key":"10.1016\/j.idnow.2026.105286_b0050","unstructured":"CRIOAc Lyon [Internet]. n.d. Recommandations [cited September 15, 2025]. Available on: https:\/\/www.crioac-lyon.fr\/documents\/recommandations\/."},{"issue":"2","key":"10.1016\/j.idnow.2026.105286_b0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/clinids\/12.2.236","article-title":"Adverse antibiotic effects associated with renal insufficiency","volume":"12","author":"Manian","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.idnow.2026.105286_b0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considerations","volume":"72","author":"Grill","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.idnow.2026.105286_b0065","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/428125","article-title":"Unique aspects of antimicrobial use in older adults","volume":"40","author":"Faulkner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2026.105286_b0070","doi-asserted-by":"crossref","unstructured":"P\u00e9hourcq F, Molimard M. [Pharmacokinetics in the elderly]. Rev Mal Respir. 2004;21(5 Pt 3):8S25-32.","DOI":"10.1016\/S0761-8425(04)71559-4"},{"issue":"2","key":"10.1016\/j.idnow.2026.105286_b0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.emcmed.2004.11.003","article-title":"Prescription m\u00e9dicamenteuse du sujet \u00e2g\u00e9","volume":"2","author":"Legrain","year":"2005","journal-title":"EMC-M\u00e9decine"},{"issue":"10","key":"10.1016\/j.idnow.2026.105286_b0080","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00003088-200544100-00002","article-title":"Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability","volume":"44","author":"Pea","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.idnow.2026.105286_b0085","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.idnow.2026.105286_b0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.pharma.2020.11.011","article-title":"Pharmacokinetic modifications and pharmacokinetic\/pharmacodynamic optimization of beta-lactams in ICU","volume":"79","author":"Matusik","year":"2021","journal-title":"Ann Pharm Fr"},{"issue":"7","key":"10.1016\/j.idnow.2026.105286_b0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.medmal.2013.05.008","article-title":"Inter-individual and intra-individual pharmacokinetic variability during teicoplanin therapy in geriatric patients","volume":"43","author":"Uhart","year":"2013","journal-title":"Med Mal Infect"},{"issue":"1","key":"10.1016\/j.idnow.2026.105286_b0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/FTD.0000000000000939","article-title":"Therapeutic drug monitoring of antibiotics in the elderly: A narrative review","volume":"44","author":"Cattaneo","year":"2022","journal-title":"Ther Drug Monit"},{"issue":"3","key":"10.1016\/j.idnow.2026.105286_b0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00134-021-06609-6","article-title":"Effect of therapeutic drug monitoring-based dose optimization of piperacillin\/tazobactam on sepsis-related organ dysfunction in patients with sepsis: A randomized controlled trial","volume":"48","author":"Hagel","year":"2022","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.idnow.2026.105286_b0110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cmi.2015.05.002","article-title":"Optimization of dosing regimens and dosing in special populations","volume":"21","author":"Sime","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2026.105286_b0115","doi-asserted-by":"crossref","unstructured":"Wong G, Sime FB, Lipman J, Roberts JA. How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients? BMC Infect Dis. 2 2014;14:288.","DOI":"10.1186\/1471-2334-14-288"},{"issue":"9","key":"10.1016\/j.idnow.2026.105286_b0120","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.clinthera.2016.06.015","article-title":"Pharmacokinetic and pharmacodynamic principles of anti-infective dosing","volume":"38","author":"Onufrak","year":"2016","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.idnow.2026.105286_b0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijantimicag.2018.09.015","article-title":"Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution","volume":"53","author":"Galar","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.idnow.2026.105286_b0130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijantimicag.2017.11.013","article-title":"Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of \u03b2-lactams administered by continuous infusion: A prospective observational study","volume":"51","author":"Carri\u00e9","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.idnow.2026.105286_b0135","doi-asserted-by":"crossref","first-page":"R279","DOI":"10.1186\/cc13134","article-title":"Optimal dosing of antibiotics in critically ill patients by using continuous\/extended infusions: A systematic review and meta-analysis","volume":"17","author":"Chant","year":"2013","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.idnow.2026.105286_b0140","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/17425255.2018.1528226","article-title":"Pharmacokinetics and drug metabolism of antibiotics in the elderly","volume":"14","author":"Pea","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"10.1016\/j.idnow.2026.105286_b0145","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s15010-019-01352-z","article-title":"Therapeutic drug monitoring-guided continuous infusion of piperacillin\/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: A retrospective analysis of four years of clinical experience","volume":"47","author":"Richter","year":"2019","journal-title":"Infection"},{"issue":"10","key":"10.1016\/j.idnow.2026.105286_b0150","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/jac\/dkx209","article-title":"Too much of a good thing: A retrospective study of \u03b2-lactam concentration-toxicity relationships","volume":"72","author":"Imani","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idnow.2026.105286_b0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007691-199902000-00010","article-title":"Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: A cost-effectiveness analysis","volume":"21","author":"van Lent-Evers","year":"1999","journal-title":"Ther Drug Monit"},{"issue":"11","key":"10.1016\/j.idnow.2026.105286_b0160","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.idnow.2026.105286_b0165","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1038\/s41598-024-58200-w","article-title":"Assessment of the practical impact of adjusting beta-lactam dosages based on therapeutic drug monitoring in critically ill adult patients: A systematic review and meta-analysis of randomized clinical trials and observational studies","volume":"14","author":"Guly\u00e1s","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.idnow.2026.105286_b0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40560-023-00699-8","article-title":"Efficacy of therapeutic drug monitoring-based antibiotic regimen in critically ill patients: A systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Takahashi","year":"2023","journal-title":"J Intensive Care"},{"issue":"10","key":"10.1016\/j.idnow.2026.105286_b0175","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/cid\/ciac506","article-title":"Beta-lactam antibiotic therapeutic drug monitoring in critically ill patients: A systematic review and meta-analysis","volume":"75","author":"Pai Mangalore","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idnow.2026.105286_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00646-22","article-title":"Effectiveness and safety of beta-lactam antibiotics with and without therapeutic drug monitoring in patients with pseudomonas aeruginosa pneumonia or bloodstream infection","volume":"66","author":"Kunz Coyne","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idnow.2026.105286_b0185","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: A position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.idnow.2026.105286_b0190","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"14","key":"10.1016\/j.idnow.2026.105286_b0195","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ajhp\/zxaa128","article-title":"Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and \u03b2-lactam antibiotics to maximize effectiveness and minimize toxicity","volume":"77","author":"Cusumano","year":"2020","journal-title":"Am J HealthSyst Pharm"},{"key":"10.1016\/j.idnow.2026.105286_b0200","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 [Internet]. 2021. Diagnostic de la d\u00e9nutrition chez l\u2019enfant, l\u2019adulte, et la personne de 70 ans et plus [cited May 8, 2026]. Available on: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-11\/reco368_fiche_outil_denutrition_pa_cd_20211110_v1.pdf."}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:15:45Z","timestamp":1789758945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991926000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666991926000436"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105286","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic drug monitoring in older adults treated with beta-lactams or daptomycin in a French tertiary hospital: A retrospective study (TEldBet)","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105286"}}